Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma

BACKGROUND: To date, multiple myeloma remains an incurable malignancy due to the persistence of minimal residual disease in the bone marrow. In this setting, monoclonal antibodies against myeloma-specific cell surface antigens represent a promising therapeutic approach, which is however hampered by...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Atanackovic, Djordje, Panse, Jens, Hildebrandt, York, Jadczak, Adam, Kobold, Sebastian, Cao, Yanran, Templin, Julia, Meyer, Sabrina, Reinhard, Henrike, Bartels, Katrin, Lajmi, Nesrine, Zander, Axel R., Marx, Andreas H., Bokemeyer, Carsten, Kröger, Nicolaus
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2011
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186313/
https://ncbi.nlm.nih.gov/pubmed/21606160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.036814
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares